Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

549 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Update on antithrombotic therapy and body mass: a clinical consensus statement of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and the European Society of Cardiology Working Group on Thrombosis.
Gigante B, Tamargo J, Agewall S, Atar D, Ten Berg J, Campo G, Cerbai E, Christersson C, Dobrev D, Ferdinandy P, Geisler T, Gorog DA, Grove EL, Kaski JC, Rubboli A, Wassmann S, Wallen H, Rocca B. Gigante B, et al. Among authors: kaski jc. Eur Heart J Cardiovasc Pharmacother. 2024 Nov 6;10(7):614-645. doi: 10.1093/ehjcvp/pvae064. Eur Heart J Cardiovasc Pharmacother. 2024. PMID: 39237457 Review.
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2023.
Tamargo J, Agewall S, Borghi C, Ceconi C, Cerbai E, Dan GA, Ferdinandy P, Grove EL, Rocca B, Magavern E, Sulzgruber P, Semb AG, Sossalla S, Niessner A, Kaski JC, Dobrev D. Tamargo J, et al. Among authors: kaski jc. Eur Heart J Cardiovasc Pharmacother. 2024 May 4;10(3):219-244. doi: 10.1093/ehjcvp/pvae013. Eur Heart J Cardiovasc Pharmacother. 2024. PMID: 38379024 Review.
Oral anticoagulation in patients with left ventricular thrombus: a systematic review and meta-analysis.
Haller PM, Kazem N, Agewall S, Borghi C, Ceconi C, Dobrev D, Cerbai E, Grove EL, Kaski JC, Lewis BS, Niessner A, Rocca B, Rosano G, Savarese G, Schnabel RB, Semb AG, Sossalla S, Wassmann S, Sulzgruber P. Haller PM, et al. Among authors: kaski jc. Eur Heart J Cardiovasc Pharmacother. 2024 Aug 14;10(5):444-453. doi: 10.1093/ehjcvp/pvae042. Eur Heart J Cardiovasc Pharmacother. 2024. PMID: 38845369
All about clinical trials.
Semb AG, Sanders J, Kaski JC. Semb AG, et al. Among authors: kaski jc. Eur Heart J Cardiovasc Pharmacother. 2024 Oct 4;10(6):484-485. doi: 10.1093/ehjcvp/pvae055. Eur Heart J Cardiovasc Pharmacother. 2024. PMID: 39147567 No abstract available.
Changes in circulating ApoJ-Glyc levels in patients with suspected acute coronary syndrome: The EDICA trial.
Kaski JC, Lluch N, Lopez-Sendon JL, Gorog DA, Antorrena-Miranda I, Avanzas P, Herrero Puente P, Sionis A, González-Juanatey JR, Íñiguez A, Cordero A, Ako E, Fernández-Avilés F, Atienza F, Recio-Mayoral A, Wu AHB, Crea F, Storey R, Badimon L, Cubedo J. Kaski JC, et al. Int J Cardiol. 2023 Nov 15;391:131291. doi: 10.1016/j.ijcard.2023.131291. Epub 2023 Aug 22. Int J Cardiol. 2023. PMID: 37619880
549 results